Victory Capital Management Inc. Boosts Stock Holdings in Perrigo Company plc $PRGO

Victory Capital Management Inc. lifted its holdings in Perrigo Company plc (NYSE:PRGO) by 5.4% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 1,546,256 shares of the company’s stock after purchasing an additional 79,213 shares during the period. Victory Capital Management Inc. owned about 1.12% of Perrigo worth $34,435,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Elo Mutual Pension Insurance Co lifted its holdings in Perrigo by 10.8% during the third quarter. Elo Mutual Pension Insurance Co now owns 28,717 shares of the company’s stock worth $640,000 after buying an additional 2,805 shares during the period. Bahl & Gaynor Inc. increased its holdings in shares of Perrigo by 5.4% in the 3rd quarter. Bahl & Gaynor Inc. now owns 2,087,075 shares of the company’s stock valued at $46,479,000 after acquiring an additional 107,774 shares during the period. Rafferty Asset Management LLC raised its position in shares of Perrigo by 9.7% in the 3rd quarter. Rafferty Asset Management LLC now owns 12,153 shares of the company’s stock worth $271,000 after acquiring an additional 1,071 shares in the last quarter. Huntington National Bank lifted its stake in shares of Perrigo by 125.0% during the 3rd quarter. Huntington National Bank now owns 2,372 shares of the company’s stock worth $53,000 after purchasing an additional 1,318 shares during the last quarter. Finally, Citigroup Inc. boosted its position in Perrigo by 110.6% during the third quarter. Citigroup Inc. now owns 89,197 shares of the company’s stock valued at $1,986,000 after purchasing an additional 46,848 shares in the last quarter. 95.91% of the stock is currently owned by institutional investors.

Perrigo Trading Down 4.0%

Perrigo stock opened at $10.75 on Monday. The company has a debt-to-equity ratio of 1.23, a quick ratio of 1.63 and a current ratio of 2.76. The stock has a market cap of $1.48 billion, a PE ratio of -1.05, a price-to-earnings-growth ratio of 1.29 and a beta of 0.41. The stock has a 50-day moving average of $14.19 and a two-hundred day moving average of $16.99. Perrigo Company plc has a one year low of $10.65 and a one year high of $29.08.

Perrigo (NYSE:PRGO) last posted its quarterly earnings data on Thursday, February 26th. The company reported $0.77 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.80 by ($0.03). The company had revenue of $1.11 billion for the quarter, compared to analyst estimates of $1.09 billion. Perrigo had a negative net margin of 33.51% and a positive return on equity of 9.41%. The business’s revenue was down 2.5% compared to the same quarter last year. During the same quarter last year, the company earned $0.93 EPS. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. On average, research analysts anticipate that Perrigo Company plc will post 2.56 EPS for the current fiscal year.

Perrigo Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 24th. Stockholders of record on Monday, March 2nd will be paid a dividend of $0.29 per share. This represents a $1.16 annualized dividend and a dividend yield of 10.8%. The ex-dividend date is Monday, March 2nd. Perrigo’s payout ratio is presently -11.28%.

Analyst Upgrades and Downgrades

A number of brokerages have commented on PRGO. Weiss Ratings reiterated a “sell (d+)” rating on shares of Perrigo in a report on Monday, December 22nd. Canaccord Genuity Group cut their price objective on shares of Perrigo from $20.00 to $17.00 and set a “buy” rating on the stock in a research report on Friday, February 27th. Zacks Research raised shares of Perrigo from a “strong sell” rating to a “hold” rating in a research report on Friday, February 13th. Argus upgraded shares of Perrigo to a “hold” rating in a research note on Wednesday, January 14th. Finally, JPMorgan Chase & Co. cut their price target on shares of Perrigo from $20.00 to $18.00 and set a “neutral” rating on the stock in a report on Monday, December 15th. One investment analyst has rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company currently has an average rating of “Hold” and an average target price of $19.33.

About Perrigo

Perrigo Company plc is a global healthcare supplier specializing in over-the-counter (OTC) and self-care products, as well as generic prescription pharmaceuticals and active pharmaceutical ingredients. The company develops, manufactures and distributes a broad array of consumer health products, including analgesics, vitamins and supplements, digestive health remedies, topical treatments, and infant formulas. Perrigo’s focus on private-label solutions has made it a leading partner for retailers and pharmacy chains seeking high-quality, value-oriented alternatives to branded medications and health supplements.

Organized across three principal business segments—Consumer Healthcare, Prescription Pharmaceuticals and Active Pharmaceutical Ingredients—Perrigo’s operations span research and development, manufacturing, quality assurance and global distribution.